002589 瑞康医药
2024/03 -
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资671,8072.51%655,388435,948638,749652,610
投资性房地产600,442-0.80%605,263625,422644,276120,910
固定资产1,821,830-1.29%1,845,5651,975,3471,922,3032,316,993
在建工程420,812-1.99%429,340315,367549,585870,886
无形资产531,285-3.82%552,391624,208478,346319,634
商誉146,6680.00%146,668146,685620,267804,507
其他非流动资产882,036-5.72%935,5991,389,680871,241490,787
5,074,881-1.84%5,170,2135,512,6575,724,7665,576,326

流动资产
货币资金4,022,756-20.51%5,060,7875,340,2124,578,7405,752,869
应收账款3,950,7334.99%3,762,9884,112,36910,285,10113,723,606
存货978,041-12.60%1,119,070954,5152,067,9382,937,580
其他流动资产1,532,528-3.99%1,596,2482,412,4603,740,4304,147,063
10,484,059-9.14%11,539,09312,819,55620,672,20926,561,118

流动负债
短期借款4,802,284-26.75%6,556,0613,839,8354,165,0279,514,031
应付票据1,506,961235.93%448,5995,157,3596,435,7463,663,461
应付帐款2,727,624-16.69%3,274,0302,557,3923,355,3034,610,733
其他流动负债545,00312.97%482,428913,8502,551,7083,379,887
9,581,872-10.96%10,761,11812,468,43716,507,78421,168,111
流动资产净值902,18715.97%777,975351,1194,164,4255,393,007
资产总额减流动负债5,977,0680.49%5,948,1885,863,7779,889,19110,969,333

非流动负债
长期借款269,5003.15%261,27467,20048,5006,700
应付债券0--0001,663
其他非流动负债52,0204.17%49,93745,244147,534445,851
321,5203.31%311,211112,444196,034454,214

总权益
    实收股本1,504,7100.00%1,504,7101,504,7101,504,7101,504,710
    储备项目3,958,2520.38%3,943,0833,902,6226,062,3255,964,346
股东权益5,462,9630.28%5,447,7945,407,3327,567,0367,469,056
非控股权益192,5851.80%189,183344,0002,126,1213,046,063